Suchergebnisse - "1871-5273" OR "1996-3181"

PubPharm (3.167)

1621

Neurokinin-1 (NK1) receptor antagonists as possible therapeutics for psychostimulant use disorders

enthalten in: CNS & neurological disorders, drug targets | 2015

von Olive, M.

1622

Dopamine D4Receptor Antagonists for the Treatment of Cocaine Use Disorders

enthalten in: CNS & neurological disorders, drug targets | 2015

von Bergman, J. | Rheingold, C.

1623

From Ancient Chinese Medicine to a Novel Approach to Treat Cocaine Addiction

enthalten in: CNS & neurological disorders, drug targets | 2015

von Diamond, I. | Yao, L.

1624

Poly(ADP)-Ribose Polymerase-1 Inhibitors as a Potential Treatment for Cocaine Addiction

enthalten in: CNS & neurological disorders, drug targets | 2015

von Scobie, K.

1625

The Actin Cytoskeleton as a Therapeutic Target for the Prevention of Relapse to Methamphetamine Use

enthalten in: CNS & neurological disorders, drug targets | 2015

von Young, E. | Briggs, S. | Miller, C.

1626

Metabotropic Glutamate Receptor 7 (mGluR7) as a Target for the Treatment of Psychostimulant Dependence

enthalten in: CNS & neurological disorders, drug targets | 2015

von Li, X. | Markou, A.

1627

Glutamate Transporter GLT-1 as a Therapeutic Target for Substance Use Disorders

enthalten in: CNS & neurological disorders, drug targets | 2015

von Roberts-Wolfe, D. | Kalivas, P.

1628

Nitric Oxide-GAPDH Transcriptional Signaling Mediates Behavioral Actions of Cocaine

enthalten in: CNS & neurological disorders, drug targets | 2015

von Harraz, M. | Snyder, S.

1629

Histone Deacetylases as Potential Targets for Cocaine Addiction

enthalten in: CNS & neurological disorders, drug targets | 2015

von Kennedy, P. | Harvey, E.

1630

Synopsis of Expert Opinions and Conclusions

enthalten in: CNS & neurological disorders, drug targets | 2015

von Skolnick, P. | White, D. | Acri, J.